409 related articles for article (PubMed ID: 18092442)
1. Metabolic syndrome: are we at risk?
Paudel B
Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metabolic syndrome.
Wagh A; Stone NJ
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
[TBL] [Abstract][Full Text] [Related]
3. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome: time for action.
Deen D
Am Fam Physician; 2004 Jun; 69(12):2875-82. PubMed ID: 15222652
[TBL] [Abstract][Full Text] [Related]
5. Unmet needs in controlling metabolic disease.
Haffner SM
Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
Rosenberg DE; Jabbour SA; Goldstein BJ
Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
[TBL] [Abstract][Full Text] [Related]
7. Treating the metabolic syndrome.
Bianchi C; Penno G; Romero F; Del Prato S; Miccoli R
Expert Rev Cardiovasc Ther; 2007 May; 5(3):491-506. PubMed ID: 17489673
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome.
Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.
Lebovitz HE
Diabetes Obes Metab; 2006 May; 8(3):237-49. PubMed ID: 16634983
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome.
Reaven P
J Insur Med; 2004; 36(2):132-42. PubMed ID: 15301226
[TBL] [Abstract][Full Text] [Related]
11. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
Lee M; Aronne LJ
Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
[TBL] [Abstract][Full Text] [Related]
12. Challenges associated with metabolic syndrome.
Spinler SA
Pharmacotherapy; 2006 Dec; 26(12 Pt 2):209S-217S. PubMed ID: 17125447
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome: diabetes and cardiovascular disease.
Gupta S; Gupta BM
Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
[TBL] [Abstract][Full Text] [Related]
14. Management of the metabolic syndrome.
Grant RW; Meigs JB
Panminerva Med; 2005 Dec; 47(4):219-28. PubMed ID: 16489321
[TBL] [Abstract][Full Text] [Related]
15. Mediterranean diet and the metabolic syndrome.
Esposito K; Ciotola M; Giugliano D
Mol Nutr Food Res; 2007 Oct; 51(10):1268-74. PubMed ID: 17879992
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk: prevention and treatment of the metabolic syndrome.
Tuomilehto J
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl 2():S28-35. PubMed ID: 15953504
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
Grundy SM
J Am Coll Cardiol; 2006 Mar; 47(6):1093-100. PubMed ID: 16545636
[TBL] [Abstract][Full Text] [Related]
18. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
Yamagishi S; Matsui T; Sato T; Takeuchi M
Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
[TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy.
Wyne KL
Diabetes Obes Metab; 2006 Jul; 8(4):365-80. PubMed ID: 16776743
[TBL] [Abstract][Full Text] [Related]
20. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
Andreadis EA; Katsanou PM; Georgiopoulos DX; Tsourous GI; Yfanti GK; Gouveri ET; Diamantopoulos EJ
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):175-80. PubMed ID: 19053032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
